ES2157435T3 - Particulas retroviricas pseudotipadas. - Google Patents

Particulas retroviricas pseudotipadas.

Info

Publication number
ES2157435T3
ES2157435T3 ES96909135T ES96909135T ES2157435T3 ES 2157435 T3 ES2157435 T3 ES 2157435T3 ES 96909135 T ES96909135 T ES 96909135T ES 96909135 T ES96909135 T ES 96909135T ES 2157435 T3 ES2157435 T3 ES 2157435T3
Authority
ES
Spain
Prior art keywords
pseudotipated
retroviral vector
retroviric
particles
mlv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96909135T
Other languages
English (en)
Inventor
Brian Salmons
Jorg Baumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Austrian Nordic Biotherapeutics AG
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Original Assignee
Austrian Nordic Biotherapeutics AG
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Austrian Nordic Biotherapeutics AG, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH filed Critical Austrian Nordic Biotherapeutics AG
Application granted granted Critical
Publication of ES2157435T3 publication Critical patent/ES2157435T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material
    • C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Optical Radar Systems And Details Thereof (AREA)
  • Eye Examination Apparatus (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN SISTEMA DE VECTOR RETROVIRAL QUE COMPRENDE UNA LINEA CELULAR DE EMPAQUETAMIENTO QUE SINTETIZA EL CORE Y LAS PROTEINAS ENZIMATICAS DEL VIRUS MLV A PARTIR DE UNO O VARIOS CONSTRUCTOS QUE CONTIENEN GAG Y POL, Y LA ENVUELTA DEL VIRUS MMTV A PARTIR DEL MISMO CONSTRUCTO O UN CONSTRUCTO INDEPENDIENTE QUE CONTIENE ENV, Y A PARTICULAS RETROVIRALES PSEUDOTIPADAS PRODUCIDAS CULTIVANDO DICHO SISTEMA DE VECTOR RETROVIRAL TRANSFECTADO CON UN VECTOR RETROVIRAL BASADO EN MLV, Y AL AISLAMIENTO DE DICHAS PARTICULAS RETROVIRALES PSEUDOTIPADAS.
ES96909135T 1995-03-29 1996-03-27 Particulas retroviricas pseudotipadas. Expired - Lifetime ES2157435T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK32795 1995-03-29

Publications (1)

Publication Number Publication Date
ES2157435T3 true ES2157435T3 (es) 2001-08-16

Family

ID=8092296

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96909135T Expired - Lifetime ES2157435T3 (es) 1995-03-29 1996-03-27 Particulas retroviricas pseudotipadas.

Country Status (8)

Country Link
EP (1) EP0817860B1 (es)
JP (1) JPH11502706A (es)
AT (1) ATE200912T1 (es)
AU (1) AU5274696A (es)
DE (1) DE69612660T2 (es)
DK (1) DK0817860T3 (es)
ES (1) ES2157435T3 (es)
WO (1) WO1996030533A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012968A1 (en) * 1995-10-05 1997-04-10 Chiron Corporation Retroviral vectors pseudotyped with srv-3 envelope glycoprotein sequences
DK0975783T3 (da) 1997-02-27 2002-01-28 Bundesrepublik Deutschland Let Retrovirusvektorer, fremgangsmåde til fremstilling heraf samt deres anvendelse til genoverføring til CD4-positive celler
EP0980264A2 (en) * 1997-05-16 2000-02-23 Leuven Research & Development vzw Mammalian cell transduction for use in gene therapy
EP0938904A1 (en) * 1998-02-09 1999-09-01 Leuven Research & Development vzw Mammalian cell transduction for use in gene therapy
FR2779445B1 (fr) * 1998-06-08 2000-08-11 Univ Nantes Kit d'encapsidation
GB0400443D0 (en) 2004-01-09 2004-02-11 Oxford Biomedica Ltd Cascade
AU2002336162A1 (en) * 2001-09-21 2003-04-01 Oxford Biomedica (Uk) Limited Pseudotyped retroviral vector system
CN121605184A (zh) * 2023-07-20 2026-03-03 香港北恒生物科技有限公司 逆转录病毒包装细胞及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023048A2 (en) * 1993-04-06 1994-10-13 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Gibbon ape leukemia virus-based retroviral vectors

Also Published As

Publication number Publication date
ATE200912T1 (de) 2001-05-15
AU5274696A (en) 1996-10-16
DK0817860T3 (da) 2001-10-01
EP0817860A1 (en) 1998-01-14
WO1996030533A1 (en) 1996-10-03
DE69612660D1 (de) 2001-06-07
DE69612660T2 (de) 2002-04-18
JPH11502706A (ja) 1999-03-09
EP0817860B1 (en) 2001-05-02

Similar Documents

Publication Publication Date Title
ATE309378T1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
ATE520783T1 (de) Lentivirale vektoren
BR9812720A (pt) Método de processamento de informação usando um assistente de comunicação pessoal
HN1996000017A (es) Isotiazolonas
TR199701252T1 (xx) Bir saponin ve bir sterol i�eren a��lar.
HUP0301659A2 (hu) Kukorica cellulóz-szintetázok és alkalmazásuk
ES2160191T3 (es) Deteccion de listerias, mediante bacteriofagos recombinantes.
GT199400073A (es) Sistema de anuncios por telefono publitel internacional
WO2007038142A3 (en) Sms+: short message service plus context support for social obligations and sms+4d: short message service plus 4-dimensional context
ES2157435T3 (es) Particulas retroviricas pseudotipadas.
DE3750125D1 (de) Biologische eindämmung.
ATE186738T1 (de) Kohlenhydratmodifizierte cytostatika
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
ATE244762T1 (de) Säugetier - expressionssysteme für hüllenprotingene des hepatitit - c - virus
DE69836814D1 (de) Zulieferausgewählte nachricht als antwort auf anwenderanfrage
DE60004197D1 (de) Packetumleiteinrichtung
WO2003016491A3 (en) Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
DE60031369D1 (de) Replikation -defektive baculoviren expressionssystem
DE60044303D1 (de) Nicht-immunsuppresives hiv tat-protein
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
ATE305159T1 (de) Feueralarmmodul
AU8405798A (en) A swine hepatitis e virus and uses thereof
PT870015E (pt) Novas xilanases os genes que as codificam e as suas utilizacoes
ATE264394T1 (de) Klonierung der udp-galaktose-epimerase
TR199901862T2 (xx) Yeni Bile�ikler.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 817860

Country of ref document: ES